February 2020 - Page 56 of 318

NASDAQ Companies - February 24, 2020

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast

NEW YORK, Feb. 24, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of and […]

NASDAQ Companies - February 24, 2020

TRxADE GROUP, INC. Announces Exercise of Overallotment Option by Underwriters

TAMPA, FL, Feb. 24, 2020 (GLOBE NEWSWIRE) — Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug […]

NASDAQ Companies - February 24, 2020

Neoleukin Therapeutics to Present at Cowen and Company 40th Annual Health Care Conference

SEATTLE, Feb. 24, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq: NLTX), a biopharmaceutical company utilizing sophisticated computational methods […]

NASDAQ Companies - February 24, 2020

Oyster Point Pharma to Present at the Cowen 40th Annual Healthcare Conference

PRINCETON, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on […]

NASDAQ Companies - February 24, 2020

Catalyst Biosciences to Present at the Cowen Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that Nassim Usman, Ph.D., […]

NASDAQ Companies - February 24, 2020

MyoKardia to Present at 40th Annual Cowen Health Care Conference

BRISBANE, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, […]

NASDAQ Companies - February 24, 2020

Zogenix to Release Fourth Quarter and Full-Year 2019 Financial Results and Host Conference Call and Webcast on March 2

EMERYVILLE, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq: ZGNX), a global pharmaceutical company developing rare disease therapies, […]